AYTU BIOPHARMA INC (AYTU) Forecast, Price Target & Analyst Ratings

NASDAQ:AYTU • US0547548588

Current stock price

2.54 USD
-0.1 (-3.79%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AYTU BIOPHARMA INC (AYTU).

Forecast Snapshot

Consensus Price Target

Price Target
$9.52
+ 274.80% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q3 / 2026
EPS Estimate
-$0.58
Revenue Estimate
13.552M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.52
Upside
+ 274.80%
From current price of $2.54 to mean target of $9.52, Based on 9 analyst forecasts
Low
$7.07
Median
$8.16
High
$13.65

Price Target Revisions

1 Month
0.00%
3 Months
1.82%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for AYTU. The average price target is 9.52 USD. This implies a price increase of 274.8% is expected in the next year compared to the current price of 2.54.
The average price target has been revised upward by 1.82% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AYTU Current Analyst RatingAYTU Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

AYTU Historical Analyst RatingsAYTU Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
AYTU was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AYTU.
In the previous month the buy percentage consensus was at a similar level.
AYTU was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-10Ascendiant CapitalMaintains Buy -> Buy
2025-09-25Ascendiant CapitalMaintains Buy -> Buy
2025-09-25Maxim GroupMaintains Buy -> Buy
2025-07-01Lake StreetInitiate Buy
2025-06-30Ascendiant CapitalInitiate Buy
2023-08-09Maxim GroupInitiate Buy
2023-05-31HC Wainwright & Co.Reiterate Buy -> Buy
2022-07-21HC Wainwright & Co.Maintains Buy
2022-05-17Cantor FitzgeraldMaintains Overweight
2022-04-28HC Wainwright & Co.Maintains Buy
2021-03-30Cantor FitzgeraldInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q3 / 2026
EPS Estimate
-$0.58
Revenue Estimate
13.552M
Revenue Q2Q
-26.56%
EPS Q2Q
-374.43%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.75%
EPS (1 Month)
-21.51%
EPS (3 Months)
-2.73%

Next Earnings Summary

AYTU is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.58 USD and the consensus revenue estimate is 13.55M USD.
The next earnings revenue estimate has been revised downward by 0.75% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
AYTU revenue by date.AYTU revenue by date.
107.4M
11.07%		65.183M
-39.31%		66.382M
1.84%		57.627M
-13.19%		83.047M
44.11%		96.389M
16.07%		131.89M
36.83%		141.07M
6.96%
EBITDA
YoY % growth
AYTU ebitda by date.AYTU ebitda by date.
-2.58M
89.32%		8.837M
442.52%		7.914M
-10.44%		-9.542M
-220.57%		3.824M
140.08%		10.568M
176.36%		N/AN/A
EBIT
YoY % growth
AYTU ebit by date.AYTU ebit by date.
-11.4M
66.86%		565K
104.96%		2.537M
349.03%		-13.735M
-641.40%		-1.832M
86.66%		4.02M
319.40%		1.122M
-72.09%		4.692M
318.18%
Operating Margin
AYTU operating margin by date.AYTU operating margin by date.
-10.61%0.87%3.82%-23.83%-2.21%4.17%0.85%3.33%
EPS
YoY % growth
AYTU eps by date.AYTU eps by date.
-5.03
93.40%		-2.86
43.14%		-2.53
11.54%		-1.68
33.48%		-0.52
69.09%		0.34
164.71%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.58
-374.43%		-0.38
87.08%
Revenue
Q2Q % growth		13.552M
-26.56%		16.234M
7.26%
EBITDA
Q2Q % growth		-3.257M
-150.08%		-1.881M
-131.27%
EBIT
Q2Q % growth		-4.396M
-281.59%		-3.025M
-572.65%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AYTU Yearly Revenue VS EstimatesAYTU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M
AYTU Yearly EPS VS EstimatesAYTU Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -50K -100K -150K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
28.73%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.97%
Revenue Next 5 Year
14.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
76.95%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AYTU BIOPHARMA INC / AYTU Forecast FAQ

Can you provide the average price target for AYTU BIOPHARMA INC stock?

9 analysts have analysed AYTU and the average price target is 9.52 USD. This implies a price increase of 274.8% is expected in the next year compared to the current price of 2.54.

Can you provide the upcoming earnings date for AYTU BIOPHARMA INC?

AYTU BIOPHARMA INC (AYTU) will report earnings on 2026-05-12.

What are the consensus estimates for AYTU BIOPHARMA INC (AYTU) next earnings?

The consensus EPS estimate for the next earnings of AYTU BIOPHARMA INC (AYTU) is -0.58 USD and the consensus revenue estimate is 13.55M USD.

What is the number of analysts for AYTU stock?

The number of analysts covering AYTU BIOPHARMA INC (AYTU) is 9.